MEDU-04. A PHASE II STUDY OF RADIOIMMUNOTHERAPY WITH INTRAVENTRICULAR 131I-3F8 FOR MEDULLOBLASTOMA

BACKGROUND: High-risk and recurrent medulloblastoma is associated with significant mortality. The murine monoclonal antibody 3F8 targets the cell-surface disialoganglioside GD2 on medulloblastoma. We tested the efficacy, toxicity, and dosimetry of compartmental radioimmunotherapy (cRIT) with intrave...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Kramer, Kim, Pandit-Taskar, Neeta, Humm, John, Zanzonico, Pat, Haque, Sofia, Dunkel, Ira, Wolden, Suzanne, Donzelli, Maria, Goldman, Debra, Lewis, Jason, Lyashchenko, Serge, Khakoo, Yasmin, Carrasquillo, Jorge, Souweidane, Mark, Greenfield, Jeffrey, Lyden, David, De Braganca, Kevin, Gilheeney, Stephen, Larson, Steven, Cheung, Nai-Kong
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5475175/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox083.155
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados